《韩国药典》KP9.0英文版电子版下载Monographs, Part I (J-Z) Korean Pharmacopoeia.pdf
- 文档编号:10502442
- 上传时间:2023-02-15
- 格式:PDF
- 页数:471
- 大小:10.21MB
《韩国药典》KP9.0英文版电子版下载Monographs, Part I (J-Z) Korean Pharmacopoeia.pdf
《《韩国药典》KP9.0英文版电子版下载Monographs, Part I (J-Z) Korean Pharmacopoeia.pdf》由会员分享,可在线阅读,更多相关《《韩国药典》KP9.0英文版电子版下载Monographs, Part I (J-Z) Korean Pharmacopoeia.pdf(471页珍藏版)》请在冰豆网上搜索。
JosamycinPropionateCHCH3OH3CHOOHCH3OHHHCH3JosamycinPropionateisaderivativeofjosamycin.JosamycinPropionatecontainsnotlessthan843g(potency)permgofjosamycin(C42H69NO15:
828.00),calculatedonthedriedbasis.DescriptionJosamycinPropionateisawhitetolightyellowishwhitecrystallinepowder,andisodorlessandtasteless.JosamycinPropionateisverysolubleinmethanolorinethanol,solubleinether,andpracticallyinsolubleinwater.Identification(l)Dissolve2mgofJosamycinPro-pionatein5mLofsulfuricacid:
thesolutionturnstored-brown.
(2)DeterminetheabsorptionspectrumofasolutionofJosamycinPropionateinmethanol(lin100000)asdirectedunderUltraviolet-visibleSpectrophotometry,itexhibitsmaximumbetween230nmand233nm.PurityHeavymetals-Proceedwith1.0gofJosamy-cinPropionateaccordingtoMethod2andperformthetest.Preparethecontrolsolutionwith3.0mLofstan-dardleadsolution(notmorethan30ppm).LossonDryingNotmorethan2.0%(0.5g,inva-cuum,60C,3hours).ResidueonignitionNotmorethan0.2%(1g).AssayTheCylinder-platemethodmethod(l)Agarmediaforseedandbaselayer-UsethemediuminI2l)
(1)CDunderMicrobialAssayforAntibiotics.
(2)Testorganism-BacillussubtilisATCC6633.(3)Weighaccuratelyabout20mg(potency)ofJo-samycinPropionate,dissolvein10mLofmethanol,andadd0.06mol/Lphosphatebuffersolution,pH5.6tomakesolutionsothateachmLcontains400.0g(potency).Takeexactlyasuitableamountofthissolu-tion,add0.06mol/Lphosphatebuffersolution,pH5.6tomakesolutionssothateachmLcontains80.0g(potency)and20.0g(potency),andusethesesolu-tionsasthehighconcentrationtestsolutionandthelowconcentrationtestsolution,respectively.Separately,weighaccuratelyabout20mgofJosamycinPropionateKP9539RS,dissolveinl0mLofmethanol,andadd0.06mol/Lphosphatebuffersolution,pH5.6tomakesolutionsothateachmLcontains400.0g(potency),andusethissolutionasthestandardstocksolution.Keepthestan-dardstocksolutionatnotexceeding5Candusewith-in3days.Takeexactlyasuitableamountofthestan-dardstocksolutionbeforeuse,add0.06mol/Lphos-phatebuffersolution,pH5.6tomakesolutionssothateachmLcontains80.0g(potency)and20.0g(po-tency),andusethesesolutionsasthehighconcentra-tionstandardsolutionandthelowconcentrationstan-dardsolution,respectively.PerformthetestwiththesesolutionsaccordingtotheCylinder-platemethod(I8)asdirectedunderMicrobialAssayforAntibiotics.PackagingandStoragePreserveintightcontainers.KanamycinMonosulfateKanamycinMonosulfateisthesulfateofanaminogly-cosidesubstancehavingantibacterialactivityproducedbythegrowthofStreptomyceskanamyceticus.KanamycinMonosulfatecontainsnotlessthan750g(potency)permgofkanamycin(C18H36N4O11:
484.50),calculatedonthedriedbasis.DescriptionKanamycinMonosulfateisawhitetoyellowishwhitepowder,isodorlessorhasalittlebitofodor,andhasalittlebitofbittertaste.KanamycinMonosulfateisfreelysolubleinwater,andpracticallyinsolubleinethanolorinether.Identification
(1)To50mgofKanamycinMonosul-fateadd3mLofwateranddissolve,andadd2mLofanthroneTS:
ablue-purplecolordevelops.
(2)To20mgofKanamycinMonosulfate,add2mLof0.06mol/Lphosphatebuffersolution,pH5.6,dis-solve,andaddlmLofninhydrinTSandboil:
ablue-purplecolordevelops.(3)To10mgofKanamycinMonosulfateadd1mLofwateranddissolve,andaddlmLofninhydrinsolu-tioninn-butanol(1in500)and0.5mLofpyridine,_andheatinwaterbathfor5minutesandaddlmLofwater:
adarkpurplecolordevelops.(4)AsolutionofKanamycinMonosulfateresponds540Monographs.PartItoQualitativeTestsforsulfatesalt.pHThepHofasolutionobtainedbydissolving0.1gofKanamycinMonosulfatein10mLofwaterisbe-tween6.5and8.5.SterilityTestItmeetstherequirement,whenKana-mycinMonosulfateisusedinasterilepreparation.BacterialEndotoxinsLessthan0.50EUpermgofkanamycin,whenKanamycinMonosulfateisusedinasterilepreparation.LossonDryingNotmorethan4.0%(0.1g,inva-cuum,60C,3hours).ResidueonIgnitionNotmorethan1.0%(1g).AssayTheCylinder-platemethodmethod
(1)Agarmediaforseedandbaselayer-UsethemediuminI21)
(1)CDunderMicrobialAssayforAntibiotics.
(2)Testorganism-BacillussubtilisATCC6633.(3)Weighaccuratelyabout20mg(potency)ofKa-namycinMonosulfate,dissolveinsterilepurifiedwater,tomakeasolutionsothateachmLcontains400.0g(potency),andusethissolutionastheteststocksolu-tion.Takeexactlyasuitableamountofthissolution,add0.1mol/Lphosphatebuffersolution,pH8.0tomakesolutionssothateachmLcontains20.0g(po-tency)and5.0g(potency),andusethesesolutionsasthehighconcentrationtestsolutionandthelowconcen-trationtestsolution,respectively.Separately,weighac-curatelyabout20mgofKanamycinSulfateRS,pre-viouslydried,dissolvein0.05mol/Lphosphatebuffersolution,pH6.0tomakesolutionsothateachmLcon-tains400.0g(potency),andusethissolutionasthestandardstocksolution.Keepthestandardstocksolu-tionbetween5Cand15C,andusewithin30days.Takeexactlyasuitableamountofthestandardstocksolutionbeforeuse,add0.1mol/Lphosphatebufferso-lution,pH8.0tomakesolutionssothateachmLcon-tains20.0g(potency)and5.0g(potency),andusethesesolutionsasthehighconcentrationstandardsolu-tionandthelowconcentrationstandardsolution,re-spectively.Performthetestwiththesesolutionsaccord-ingtotheCylinder-platemethod(I8)asdirectedunderMicrobialAssayforAntibiotics.PackagingandStoragePreserveintightcontainers.KanamycinSulfateKanamycinSulfateisthesulfateofanaminoglycosidesubstancehavingantibacterialactivityproducedbythegrowthofStreptomyceskanamyceticus.KanamycinSulfateispreparedbyaddingnotmorethan1molofsulfuricacidto1molofkanamycinmonosul-fate.KanamycinSulfatecontainsnotlessthan600g(po-tency)permgofkanamycin(C18H35N4O11:
484.50),calculatedonthedriedbasis.DescriptionKanamycinSulfateisawhitetoyello-wishwhitepowder,isodorlessorhasalittlebitofodor,andhasalittlebitofbittertaste.KanamycinSulfateisverysolubleinwater,andpracti-callyinsolubleinethanol,inacetone,orinether.IdentificationPerformthetestaccordingtoIdentifi-cationin_KanamycinMonosulfate.pHThepHofasolutionobtainedbydissolving0.5gofKanamycinMonosulfatein10mLofwaterisbe-tween6.0and8.5.SterilityTestItmeetstherequirement,whenKana-mycinSulfateisusedinasterilepreparation.PyrogenTestItmeetstherequirement,whenKana-mycinSulfateisusedinasterilepreparation,.WeighanappropriateamountofKanamycinSulfate,dissolveinwater,makethesolutionsothateachmLcontains10.0mg,andusethesolutionasthetestsolution.Theamountofinjectionis1.0mLofthetestsolutionperkgofbodyweightofrabbit.LossonDryingNotmorethan5.0%(0.1g,inva-cuum,60C,3hours).AssayPerformthetestaccordingtoAssayin_Kana-mycinMonosulfate.Weighaccuratelyabout20mg(potency)ofKanamycinSulfate,dissolveinsterilepu-rifiedwatertomakeasolutionsothateachmLcon-tains400.0g(potency),andusethissolutionastheteststocksolution.Takeexactlyasuitableamountofthissolution,add0.1mol/Lphosphatebuffersolution,pH8.0tomakesolutionssothateachmLcontains20.0g(potency)and5.0g(potency),andusethesesolu-tionsasthehighconcentrationtestsolutionandthelowconcentrationtestsolution,respectively.PackagingandStoragePreserveintightcontainers.KainicAcidH(NC02HHAT:
H2C02HH20H2C=CRICH3KainicAcid,previouslydried,containsnotlessthan99.0%andnotmorethan101.0%ofkainicacid(C10H1sNO4:
213.23).DescriptionKainicAcidiswhitecrystalsorcrystal-linepowder,isodorlessandhasanacidtaste.KainicAcidissparinglysolubleinwaterorinwarmwater,veryslightlysolubleinglacialaceticacidorinethanolandpracticallyinsolubleinether.KainicaciddissolvesindilutehydrochloricacidorinsodiumhydroxideTS.Meltingpoint-About252C(withdecomposition).pH-ThepHofasolutionofKainicAcid(1in100)isbetween2.8and3.5.Identification
(1)To5mLofasolutionofKainicAcid(1in5000),add1mLofninhydrinTSandwarminawater-bathatatemperaturebetween60Cand70Cfor5minutes:
ayellowcolorisproduced.
(2)Dissolve50mgofKainicAcidin5mLofgla-cialaceticacidandadd0.5mLofbromineTS:
thecol-orofbrominedisappearsimmediately.SpecificOpticalRotationa0:
Between-13and-17(0.5g,water,50mL,200mm).Purity
(1)Clarityandcolorofsolution-Dissolve0.10gofKainicAcidin10mLofwater:
thesolutionisclearandcolorless.
(2)Chloride-Take0.5gofKainicAcidinaplati-numcrucible,dissolvein5mLofsodiumcarbonateTSandevaporateInawater-bathtodryness.Heatthecruc-ibleslowlyatfirstandthenigniteuntilthesampleisalmostincinerated.Aftercooling,add12mLofdilutenitricacidtotheresidue,dissolvebywarmingandfilter.Washtheresiduewith15mLofwater,combinethewashingsandthefiltrateandaddwatertomake50mL.KP9541Performthetest(notmorethan0.021%).Controlsolution-Add5mLofsodiumcarbonateTSto0.30mLof0.01mol/LhydrochloricacidVSandproceedasdirectedabove.(3)Sulfate-Dissolve0.5gofKainicAcidin40mLofwaterbywarming.Cool,add1mLofdilutehy-drochloricacidandwatertomake50mLandperformthetest.Preparethecontrolsolutionwith0.30mLof0.005mol/LsulfuricacidVS(notmorethan0.028%).(4)Ammonium-Take0.25gofKainicAcidandperformthetest.Preparethecontrolsolutionwith5.0mLofstandardammoniumsolution(notmorethan0.02%).(5)Heavymetals-Proceedwith1.0gofKainicAcidaccordingto
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 韩国药典 韩国药典KP9.0英文版电子版下载Monographs Part J-Z Korean Pharmacopoeia 韩国 药典 KP9 英文 电子版 下载 Monographs
链接地址:https://www.bdocx.com/doc/10502442.html